Specialty Pharma Journal Specialty, Precision & Technology

RHB-104 has been granted Qualified Infectious Disease Product (QIDP) designation by the U.S. FDA for …

INDIANAPOLIS, Jan. 13, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation …

PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc., a company focused on enabling the mastery of biology by …

PALO ALTO, Calif. and DARMSTADT, Germany, Jan. 12, 2017 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, …

WALTHAM, Mass., Jan. 11, 2017 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, …

Washington, DC, January 12, 2017 – The Biosimilars Forum – the nonprofit organization solely dedicated to …

Capturing real-time reports of cancer patients’ symptoms between doctor’s visits has proven health benefits, but …

The autoimmune skin disease called psoriasis tends to be associated with other health concerns, including …

INDIANAPOLIS, Jan. 11, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the …

LAVAL, Quebec, Jan. 10, 2017 /PRNewswire/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: …

LAUSANNE, Switzerland & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anokion, a privately held biopharmaceutical company developing novel tolerance-inducing therapeutics …

HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, Jan. 11, 2017 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: …

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial stage developer of innovative RNA-targeted therapeutics, today announced …

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …

NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug …